Sight Sciences reaffirms its revenue guidance for 2023 and expresses concern over proposed Medicare coverage determination for non-implantable MIGS procedures.
AI Assistant
SIGHT SCIENCES INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.